MedPath

The study is a comparative study between intravenous Lignocaine with intravenous Lignocaine and magnesium sulphate combination for laparoscopic Nephrectomy to evaluate the effectiveness of pain management during post operative in 24 hours

Phase 4
Not yet recruiting
Conditions
To assess the effectiveness of post operative pain in laparoscopic nephrectomy
Registration Number
CTRI/2022/03/041115
Lead Sponsor
Indhira gandhi institue of medical sciencePatna
Brief Summary

The study is  taken to compare the management of pain in post laparoscopic Nephrectomy with the combination of intravenous Lignocaine and the combination of intravenous Lignocaine and magnesium sulphate for better pain control during the post operative period

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Elective laparoscopic Nephrectomy.

Exclusion Criteria

1 Refused consent, 2 Allergic to local anaesthetic agent and opiods 3 on long term analgesic to chronic pain 4 Impaired liver function 5 Has a history of arrhythmia 6 Viral marker reactive 7 Covid 19 positive.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
quality of recovery scoreat 24 hr postoperative period
Secondary Outcome Measures
NameTimeMethod
hemodynamics every 30 min after starting infusion.NRS pain score

Trial Locations

Locations (1)

Indira Gandhi Institute of Medical Sciences

🇮🇳

Patna, BIHAR, India

Indira Gandhi Institute of Medical Sciences
🇮🇳Patna, BIHAR, India
Manom Konyak
Principal investigator
8731955881
nokzei22@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.